| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PSA | Common Stock | Options Exercise | $822,982 | +5,163 | +17% | $159.40 | 35,163 | 13 Mar 2023 | Direct | |
| holding | PSA | Common Stock | 1,000 | 13 Mar 2023 | By IRA | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PSA | Stock Option (Right to Buy) | Options Exercise | $0 | -5,163 | -100% | $0.000000* | 0 | 13 Mar 2023 | Common Stock | 5,163 | $159.40 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | By the custodian of an IRA for the benefit of Avedick B. Poladian. |
| F2 | Stock option granted pursuant to the 2007 Equity and Performance-Based Incentive Compensation Plan. Option vests in three (3) equal annual installments beginning one (1) year from grant date. |
| F3 | This option was previously reported as an option for 5,000 shares of common stock at an exercise price of $164.62, but, pursuant to anti-dilution provisions of the Company's 2007 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by the Company on July 22, 2022. |